Repros Therapeutics, Inc. (RPRX) Tops Q4 EPS by 6c

Repros Therapeutics, Inc. (NASDAQ: RPRX) reported Q4 EPS of ($0.22), $0.06 better than the analyst estimate of ($0.28). Revenue for the quarter came in at $1 thousand.

For earnings history and earnings-related data on Repros Therapeutics, Inc. (RPRX) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• JPMorgan Downgrades JD Logistics Inc (2618:HK) (JDLGF) to Neutral
• Silexion Therapeutics (SLXN) Tops Q2 EPS by 793c